INDV
Indivior Pharmaceuticals, Inc.
Stock
$35.71+0.33 (+0.93%)Close Oct 2, 2026
- EBITDA, 2025
- $272M
- YoY, 2025
- +403.7%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $272M | +403.7% |
| 2024 | $54M | — |
| 2023 | −$137M | — |
| 2022 | −$61M | — |
| 2021 | $226M | — |
Indivior Pharmaceuticals, Inc.
$35.71+0.33 (+0.93%)Close Oct 2, 2026
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $272M | +403.7% |
| 2024 | $54M | — |
| 2023 | −$137M | — |
| 2022 | −$61M | — |
| 2021 | $226M | — |